368 related articles for article (PubMed ID: 8871925)
1. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
[TBL] [Abstract][Full Text] [Related]
2. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
[TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers.
Shiao YH; Diwan BA; Perantoni AO; Calvert RJ; Zbar B; Lerman MI; Rice JM
Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699
[TBL] [Abstract][Full Text] [Related]
6. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
Gnarra JR; Lerman MI; Zbar B; Linehan WM
Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
[TBL] [Abstract][Full Text] [Related]
7. Screening for renal carcinoma associated mutations in the von Hippel-Lindau tumor suppressor gene by temperature gradient gel electrophoresis.
Wenzel M; Enczmann J; Uhrberg M; Hernández A; Wiese U; Ackermann R; Schmitz-Draeger B; Ebert T; Wernet P
Electrophoresis; 1997 Jan; 18(1):45-51. PubMed ID: 9059819
[TBL] [Abstract][Full Text] [Related]
8. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
[TBL] [Abstract][Full Text] [Related]
9. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
Zhuang Z; Roth MJ; Emmert-Buck MR; Lubensky IA; Liotta LA; Solomon D
Acta Cytol; 1994; 38(5):671-5. PubMed ID: 8091895
[TBL] [Abstract][Full Text] [Related]
10. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.
Zhuang Z; Bertheau P; Emmert-Buck MR; Liotta LA; Gnarra J; Linehan WM; Lubensky IA
Am J Pathol; 1995 Mar; 146(3):620-5. PubMed ID: 7887444
[TBL] [Abstract][Full Text] [Related]
11. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
[TBL] [Abstract][Full Text] [Related]
12. Establishment of experimental conditions for the rapid detection of mutations in the von Hippel-Lindau gene by parallel temperature gradient gel electrophoresis.
Hernández A; Meyer A; Enczmann J; Ackermann R; Wernet P
Electrophoresis; 1999 Jul; 20(10):1958-61. PubMed ID: 10451103
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H
Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
16. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
20. Multifocal renal oncocytoma in a patient with Von Hippel-Lindau mutation.
Fiske J; Patel R; Kau E; Pappas JG; Garcia RA; Taneja SS
Urology; 2005 Dec; 66(6):1320. PubMed ID: 16360474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
